Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
 |
Männedorf, Switzerland, September 3, 2013 – Molecular biologists at the Austrian Agency for Health and Food Safety rely on two Freedom EVO® workstations to perform automated nucleic acid extraction as part of a busy routine veterinary surveillance workload. Dr Sandra Revilla Fernández, Head of the Molecular Biology Department, explained: “As part of a compulsory European Union surveillance program for the H5N1 avian influenza virus, we were receiving hundreds of dead wild birds every day and performing all our nucleic acid extractions by hand; it was crazy! We needed to automate our laboratory as much as we could, as quickly as we could. Colleagues across Europe working in the same field recommended the Freedom EVO 150 workstation, and this open, flexible platform suited me perfectly; I knew that avian influenza was just the tip of the iceberg, and that our workload was going to significantly grow in the future.”
“The Freedom EVO gives us the flexibility to prepare different sample types, as well as to automate both vacuum- and magnetic bead-based methods, and can complete our extraction protocol in around two hours, with real-time PCR taking a further two and a half hours. The system is very reliable, and its efficient washing procedures help to avoid cross-contamination. We have since purchased a second Freedom EVO in response to an outbreak of bluetongue throughout Europe and, with two Freedom EVO systems and a superefficient workflow, we know we will have the results ready on time!”
To find out more on Tecan’s genomics solutions, visit www.tecan.com/genomics
For more information please contact
Tecan Trading AG
Cornelia Kegele, Antonietta Allocca
Seestrasse 103
CH-8708 Männedorf
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2012, Tecan generated sales of CHF 391 million (USD 416 million; EUR 323 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).